🇯🇵 CONDOLIASE in Japan

PMDA authorised CONDOLIASE on 23 March 2018

Marketing authorisation

PMDA — authorised 23 March 2018

  • Marketing authorisation holder: Seikagaku Corporation
  • Status: approved

CONDOLIASE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in Japan

Frequently asked questions

Is CONDOLIASE approved in Japan?

Yes. PMDA authorised it on 23 March 2018.

Who is the marketing authorisation holder for CONDOLIASE in Japan?

Seikagaku Corporation holds the Japanese marketing authorisation.